Synthesis and structure of an unexpected platinum π complex formed from substituted 1,4-diamino ligands through an elimination process

Chemistry - A European Journal

Volumn 11, Issue 7, 2005, Pages 2130-2134

  Gay, Marina ^a   Montaña, Ángel M ^a   Moreno, Virtudes ^a   Font Bardia, Mercè ^a   Solans, Xavier ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Antitumor agents; Diamines; Elimination; Pi complex; Platinum

Indexed keywords

AMINO ACIDS; COMPLEXATION; COORDINATION REACTIONS; MOLECULAR STRUCTURE; OLEFINS; SUBSTITUTION REACTIONS; X RAY DIFFRACTION ANALYSIS;

ANTITUMOR AGENTS; DIAMINES; ELIMINATION; PLATINUM COMPLEX;

PLATINUM COMPOUNDS;

1,2 BIS[(N,N DIMETHYLAMINO)METHYL]CYCLOHEXANE; ALKENE; AMINE; CYCLOHEXANE DERIVATIVE; LIGAND; PLATINUM DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; CRYSTAL; ELECTRON; SPECTROSCOPY; STEREOSPECIFICITY; X RAY DIFFRACTION;

CRYSTALLOGRAPHY, X-RAY; CYCLOHEXANES; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; ORGANOPLATINUM COMPOUNDS; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY;

EID: 15944420526     PISSN: 09476539     EISSN: None     Source Type: Journal    
DOI: 10.1002/chem.200401228     Document Type: Article

References (19)

1. L. R. Kelland, C. D. Barnard, Drugs Future 1999, 23(10), 1062-1065.
2. a) E. Wong, C. M. Giandomenico, Chem. Rev. 1999, 99, 2451-2466;
3. b) "Cisplatin and Related Drugs": P. Pil, S. J. Lippard in Encyclopedia of Cancer, Vol. 1, Academic Press, San Diego, 1997, pp. 392-410;
4. c) V. Aletras, D. Hadjiliadis, N. Hadjiliadis, Met.-Based Drugs 1995, 2, 153-184;
5. d) M. Green, M. Garner, D. M. Orton, Transition Met. Chem. 1992, 17, 164-176;
6. e) K. R. Harrap, Cancer Treat. Rev. 1985, 12, 21-33;
7. f) W. I. Sundquist, S. J. Lippard, Coord. Chem. Rev. 1990, 100, 293-322;
8. g) J. Reedijk, Chimia 1997, 51, 21-23.
9. D. B. Brown, A. R. Khokhar, M. P. Hacker, J. J. McCormack, Inorg. Chim. Acta 1982, 67, 45-52.
10. R. G. Denning, L. M. Venanzi, J. Chem. Soc. 1963, 3241-3247.
11. a) B. Lippert, BioMetals 1992, 5, 195-208;
12. b) M. J. Bloemink, J. Reedijk in Cisplatin and Derived Anticancer Drugs. Mechanism and Current Status of DNA Binding in Metal Ions in Biological Systems, Vol. 32 (Eds.: H. Sigel, A. Sigel), Marcel Dekker, New York, 1996, pp. 641-685.
13. C. Navarro-Ranninger, I. López-Solera, J. M. Pérez, P. R. Raithby, J. L. García-Ruano, J. H. Rodríguez, J. R. Masaguer, C. Alonso, J. Med. Chem. 1993, 36, 3795-3801.
14. E. D. Middlemas, L. D. Quin, J. Org. Chem. 1979, 44, 2587-2589.
15. J. M. Brown, P. A. Chaluner, B. A. Murrer, D. Parker in Stereochemistry of Optically Active Transition Metal Compounds (Eds.: B. E. Douglas, Y. Saito), A. C. S. Symposium Series No. 199, Washington D. C., 1980, p. 171.
16. R. G. Nuzzo, T. J. McCarthy, G. M. Whitesides, J. Am. Chem. Soc. 1981, 103, 3404-3410.
17. G. M. Sheldrick, SHELX, a computer program for determination of crystal structure, University Göttingen, Germany, 1996.
18. G. M. Sheldrick, SHELXS-96, a computer program for determination of crystal structure, University Göttingen, Germany, 1996.
19. International Tables of X-ray Crystallography, Vol. IV, Kynoch, 1974, pp. 99-100 and 149.